UB Paderborn / Katalog / Suche / in CDI

PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity

Cell reports (Cambridge), 2017-08, Vol.20 (8), p.1818-1829

2017

Volltextzugriff (PDF)

Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?

International journal of molecular sciences, 2022-02, Vol.23 (4), p.2022

2022

Volltextzugriff (PDF)

Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer

Frontiers in immunology, 2022-11, Vol.13, p.985886-985886

2022

Volltextzugriff (PDF)

Overcoming T cell dysfunction in acidic pH to enhance adoptive T cell transfer immunotherapy

Oncoimmunology, 2022-12, Vol.11 (1), p.2070337-2070337

2022

Volltextzugriff (PDF)

Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination

Frontiers in immunology, 2022-10, Vol.13, p.991311-991311

2022

Volltextzugriff (PDF)

Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses Against Hepatocellular Carcinoma

Cancers, 2020-11, Vol.12 (11), p.3397

2020

Volltextzugriff (PDF)

Neoantigens as potential vaccines in hepatocellular carcinoma

Journal for immunotherapy of cancer, 2022-02, Vol.10 (2), p.e003978

2022

Volltextzugriff (PDF)

Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses

Emerging microbes & infections, 2021-01, Vol.10 (1), p.1931-1946

2021

Volltextzugriff (PDF)

The Toll like receptor 4 ligand cold-inducible RNA-binding protein as vaccination platform against cancer

Oncoimmunology, 2018-04, Vol.7 (4), p.e1409321-e1409321

2018

Volltextzugriff (PDF)

A Proteomic Atlas of Lineage and Cancer-Polarized Expression Modules in Myeloid Cells Modeling Immunosuppressive Tumor-Infiltrating Subsets

Journal of personalized medicine, 2021-06, Vol.11 (6), p.542

2021

Volltextzugriff (PDF)

When Cancer Vaccines Go Viral

Clinical cancer research, 2019-08, Vol.25 (16), p.4871-4873

2019

Volltextzugriff (PDF)

Improved dendritic cell‐based immunization against hepatitis C virus using peptide inhibitors of interleukin 10

Hepatology (Baltimore, Md.), 2011-01, Vol.53 (1), p.23-31

2011

Volltextzugriff (PDF)

Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model

Cancer Immunology, Immunotherapy, 2019-03, Vol.68 (3), p.379-393

2019

Volltextzugriff (PDF)

Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection

Molecular therapy. Methods & clinical development, 2015-01, Vol.2, p.15006-15006, Article 15006

2015

Volltextzugriff (PDF)

The role of dendritic cells in the immune niche of the peritoneum

International review of cell and molecular biology, 2022, Vol.371, p.1-14

2022

Volltextzugriff (PDF)

ICOS Costimulation at the Tumor Site in Combination with CTLA-4 Blockade Therapy Elicits Strong Tumor Immunity

Molecular therapy, 2019-11, Vol.27 (11), p.1878-1891

2019

Volltextzugriff (PDF)

Leptin Expression in the Rat Ovary Depends on Estrous Cycle

The journal of histochemistry and cytochemistry, 2003-10, Vol.51 (10), p.1269-1277

2003

Volltextzugriff (PDF)

Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy

Cancer letters, 2021-02, Vol.499, p.279-289

2021

Volltextzugriff (PDF)

Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma

Nature medicine, 2023-03, Vol.29 (3), p.632-645

2023

Volltextzugriff (PDF)

IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccination

Oncotarget, 2017-01, Vol.8 (2), p.2659-2671

2017

Volltextzugriff (PDF)

FRI476 - Identification of neoantigens as potential vaccines in hepatocellular carcinoma

Journal of hepatology, 2020-08, Vol.73, p.S634-S635

2020

Volltextzugriff (PDF)

Identification of neoantigens as potential vaccines in hepatocellular carcinoma

Journal of hepatology, 2020-08, Vol.73, p.S634-S635

2020

Volltextzugriff (PDF)

Abstract 1059: Enhanced anti-tumor efficacy of a checkpoint inhibitor in combination with the HDAC inhibitor belinostat in a murine hepato-cellular carcinoma preclinical model

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.1059-1059

2017

Volltextzugriff (PDF)

Blockage of FOXP3 transcription factor dimerization and FOXP3/AML1 interaction inhibits T regulatory cell activity: sequence optimization of a peptide inhibitor

Oncotarget, 2017-09, Vol.8 (42), p.71709-71724

2017

Volltextzugriff (PDF)

A peptide inhibitor of FOXP3 impairs regulatory T cell activity and improves vaccine efficacy in mice

The Journal of immunology (1950), 2010-11, Vol.185 (9), p.5150-5159

2010

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity

Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?

Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer

Overcoming T cell dysfunction in acidic pH to enhance adoptive T cell transfer immunotherapy

Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination

Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses Against Hepatocellular Carcinoma

Neoantigens as potential vaccines in hepatocellular carcinoma

Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses

The Toll like receptor 4 ligand cold-inducible RNA-binding protein as vaccination platform against cancer

A Proteomic Atlas of Lineage and Cancer-Polarized Expression Modules in Myeloid Cells Modeling Immunosuppressive Tumor-Infiltrating Subsets

When Cancer Vaccines Go Viral

Improved dendritic cell‐based immunization against hepatitis C virus using peptide inhibitors of interleukin 10

Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model

Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection

The role of dendritic cells in the immune niche of the peritoneum

ICOS Costimulation at the Tumor Site in Combination with CTLA-4 Blockade Therapy Elicits Strong Tumor Immunity

Leptin Expression in the Rat Ovary Depends on Estrous Cycle

Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy

Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma

IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccination

FRI476 - Identification of neoantigens as potential vaccines in hepatocellular carcinoma

Identification of neoantigens as potential vaccines in hepatocellular carcinoma

Abstract 1059: Enhanced anti-tumor efficacy of a checkpoint inhibitor in combination with the HDAC inhibitor belinostat in a murine hepato-cellular carcinoma preclinical model

Blockage of FOXP3 transcription factor dimerization and FOXP3/AML1 interaction inhibits T regulatory cell activity: sequence optimization of a peptide inhibitor

A peptide inhibitor of FOXP3 impairs regulatory T cell activity and improves vaccine efficacy in mice

Suchergebnisse filtern